通过皮肤去除生物假体中枢植被:在复发性传染性内心炎中保持膜功能
Abdulaziz Al Asmari1, Kwan Leung Chan1
1Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
JACC. Case reports
|December 12, 2025
概括
使用AngioVac系统进行皮肤脱皮,在高风险患者中成功治疗了假肢 mitra 内心炎. 这种最少的侵入性方法最大限度地降低了栓塞风险,并保留了门功能.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 假肢心肌内心炎具有显著的发病率,特别是在栓塞并发症.
- 高风险患者经常面临重复手术干预的限制.
研究的目的:
- 评估使用AngioVac系统对非手术候选人进行假肢心肌内心炎的皮肤穿脱皮疗法的疗效.
- 评估这种微创方法的安全性和长期结果.
主要方法:
- 通过交叉的方法被用于通过皮肤去除Streptococcus mutans植被在一个中枢生物假体上.
- 在经食道心声学和光学指导下使用AngioVac系统.
- 术后进行了长期抑制性抗生素治疗.
主要成果:
- 成功地通过皮肤去除左侧假植被.
- 该程序将栓塞风险降到最低,并保留了本地门功能.
- 在30个月的随访期内,该患者仍然没有复发性内心炎,门结构完好.
结论:
- 使用AngioVac系统的真空辅助除是对患有假肢心膜内心炎的高风险患者重新手术的可行替代方案.
- 这种成像导向吸收技术提供了一个不那么侵入性的选择,保留门功能并减少栓塞潜力.
相关概念视频
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Endocarditis III: Medical Management
197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197
Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380
Endocarditis I: Introduction
362
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
362
Mitral Stenosis I: Introduction
386
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386


